4//SEC Filing
OncoMed Pharmaceuticals Inc 4
Accession 0001140361-15-029336
CIK 0001302573operating
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 4:21 PM ET
Size
9.6 KB
Accession
0001140361-15-029336
Insider Transaction Report
Form 4
Gurney Austin
See Remarks
Transactions
- Sale
Common Stock
2015-07-29$20.68/sh−7,000$144,758→ 56,419 total - Sale
Common Stock
2015-07-30$21.47/sh−1,099$23,592→ 49,419 total - Sale
Common Stock
2015-07-30$21.01/sh−5,901$124,009→ 50,518 total
Footnotes (5)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 29, 2015.
- [F2]This transaction was executed in multiple trades in prices ranging from $20.28 to $21.095, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 20,000 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit.
- [F4]This transaction was executed in multiple trades in prices ranging from $20.40 to $21.37, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F5]This transaction was executed in multiple trades in prices ranging from $21.41 to $21.51, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
OncoMed Pharmaceuticals Inc
CIK 0001302573
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001302573
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 4:21 PM ET
- Size
- 9.6 KB